HemAssist Unlikely
Anton Berlin
http://www.cyclingnews.com/news/experts-call-armstrong-hemassist-connection-unlikely
The best reasoning is the positive EPO test in 1999 - even LA
wouldn't be stupid enough to mix unknowns.
As well we know Lance prefers testosterone and blood boosting.
HemAssist is a red herring.
Plano Dude
>
> The best reasoning is the positive EPO test in 1999 - even LA
> wouldn't be stupid enough to mix unknowns.
>
> As well we know Lance prefers testosterone and blood boosting.
>
> HemAssist is a red herring.
Too bad nobody ever let Dario Frigo in on the joke.
Anton Berlin
http://www.cyclingnews.com/news/experts-call-armstrong-hemassist-connection-unlikely
Blood substitute ineffective, says new report
Following on the heels of the Sports Illustrated exposé which reported
that US federal investigators had assembled evidence that Lance
Armstrong had access to a blood substitute in clinical trials, a new
report by the Associated Press claims the product, HemAssist, would
have been ineffective as a performance enhancing drug.
SI reporters delved through hundreds of documents in an attempt to
uncover the details of the investigation's evidence in the case, which
is reportedly looking into claims made by Floyd Landis that there was
organized doping within Armstrong's US Postal team during the
2002-2004 seasons.
The report states that the investigators have information that
Armstrong gained access to HemAssist in the late 1990s. The drug, a
"Diaspirin Cross-Linked Hemoglobin (DCLHb), was developed as an
emergency blood substitute for trauma cases, and could, in theory,
boost the blood's oxygen-carrying capabilities and provide a
performance-enhancing benefit for aerobic sports.
While the SI report never alleges Armstrong actually used the drug, it
quoted former Baxter researcher Robert Przybelski as saying a drug
like HemAssist would be an ideal product to replace EPO - one that
could have the same effect without the negative side-effects of blood
thickening and strokes. He added that there may have been supplies of
the drug remaining after the trial ended, but he was not aware of any
missing quantities.
Speaking to the Associated Press today, Przybelski clarified that he
didn't believe athletes ever used HemAssist.
"I could not imagine a cyclist using HemAssist or any HBOC day after
day ... I would imagine that such a product would be used selectively
for a most difficult mountain stage," he told AP. "But of course," he
added, "I don't believe these products were ever used."
Armstrong's spokesman, Mark Fabiani, told Cyclingnews that because the
product was in clinical trials and kept secure, and was discontinued
by Baxter Healthcare, Inc, in late 1998 while still under trial, it
was "impossible for Lance Armstrong to have obtained HemAssist during
the period alleged by SI".
The AP story also cites several experts who agree that HemAssist was
unlikely to have been responsible for Armstrong's winning
performances.
Yorck Olaf Schumacher, a researcher at the Freiburg University in
Germany who was part of the study of a drug similar to HemAssist
called Hemopure, said that hemoglobin-based oxygen carriers (HBOCs)
showed no performance benefit. "There's nothing up to now that shows
or proves that it improves performance," he told AP.
Michel Audran, a researcher at the University of Montpellier and one
of the developers of the test to detect EPO, also participated in the
Hemopure study and said that while it was "better than HemAssist and
it didn't improve performance, so it would surprise me that he
(Armstrong) took this for nothing."
Audran said that the experience of Spanish rider Jesus Manzano, who
claims he was injected with an HBOC and then collapsed at the 2003
Tour de France, ended any experimentation with the drug in the
professional peloton.
The World Anti-Doping Agency implemented a test for HBOCs in 2004, and
there have never been any athletes who have been declared positive for
its use.
The HemAssist allegation was only part of a 10-page report which
collects a long list of anecdotes linking Armstrong to doping, all of
which Fabiani called "the same tired old lies from the same old tired
liars".
Fred Flintstein
> The AP story also cites several experts who agree that HemAssist was
> unlikely to have been responsible for Armstrong's winning
> performances.
>
> Yorck Olaf Schumacher, a researcher at the Freiburg University in
> Germany who was part of the study of a drug similar to HemAssist
> called Hemopure, said that hemoglobin-based oxygen carriers (HBOCs)
> showed no performance benefit. "There's nothing up to now that shows
> or proves that it improves performance," he told AP.
>
> Michel Audran, a researcher at the University of Montpellier and one
> of the developers of the test to detect EPO, also participated in the
> Hemopure study and said that while it was "better than HemAssist and
> it didn't improve performance, so it would surprise me that he
> (Armstrong) took this for nothing."
At this time I would like to point out that the people that
Laff was quoting as claiming that the shit was way more
effective than EPO work in accountancy.
Fred Flintstein
RicodJour
wrote:
>
> At this time I would like to point out that the people that
> Laff was quoting as claiming that the shit was way more
> effective than EPO work in accountancy.
Yes, but were they chartered accountants?
Chartered accountants are really swinging people.
http://www.youtube.com/watch?v=NrbZPIu5G-k
With high aspirations.
http://www.youtube.com/watch?v=XMOmB1q8W4Y
And unpredictable and dangerous.
http://www.youtube.com/watch?v=ecFBcpY9NHI
R
Anton Berlin
And you missed this ?
RicodJour
You wound me. I've had that clip saved on my computer since roughly
1640. It's an oldie but goodie.
R